New Targets, New Treatments, and New Combinations for the Management of Advanced Prostate Cancer
New Targets, New Treatments, and New Combinations for the Management of Advanced Prostate Cancer is organized by Physicians' Education Resource, LLC (PER).
Release Date: March 15, 2023
Expiration Date: March 15, 2024
Description:
This online, on-demand virtual symposium brings together renowned experts in metastatic castration resistant prostate cancer (CRPC). In this educational program, the faculty provides expert interpretation of new and emerging data on the treatment of metastatic CRPC, with a forward-looking perspective on how new and novel agents might impact clinical practice.
This educational activity is an archive of the live symposium held on February 16, 2023.
Learning Objectives:
Upon successful completion of this activity, you should be better prepared to:
Describe the pathophysiological mechanisms underlying current/emerging therapeutic approaches for the treatment of patients with CRPC.
Assess practice-changing evidence on evolving therapeutic strategies for patients with nonmetastatic and metastatic CRPC.
Determine measures to monitor for and mitigate the impact on outcomes of treatment-related adverse events in CRPC care settings.
Apply recent guidelines and evidence from pivotal trials to inform treatment decisions among patients with CRPC across lines of care.